Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples - a systematic review and meta-analysis

Berit Lange, Teri Roberts, Jennifer Cohn, Jamie Greenman, Johannes Camp, Azumi Ishizaki, Luke Messac, Edouard Tuaillon, Philippe van de Perre, Christine Pichler, Claudia M Denkinger, Philippa Easterbrook, Berit Lange, Teri Roberts, Jennifer Cohn, Jamie Greenman, Johannes Camp, Azumi Ishizaki, Luke Messac, Edouard Tuaillon, Philippe van de Perre, Christine Pichler, Claudia M Denkinger, Philippa Easterbrook

Abstract

Background: The detection and quantification of hepatitis B (HBV) DNA and hepatitis C (HCV) RNA in whole blood collected on dried blood spots (DBS) may facilitate access to diagnosis and treatment of HBV and HCV infection in resource-poor settings. We evaluated the diagnostic performance of DBS compared to venous blood samples for detection and quantification of HBV-DNA and HCV-RNA in two systematic reviews and meta-analyses on the diagnostic accuracy of HBV DNA and HCV RNA from DBS compared to venous blood samples.

Methods: We searched MEDLINE, Embase, Global Health, Web of Science, LILAC and Cochrane library for studies that assessed diagnostic accuracy with DBS. Heterogeneity was assessed and where appropriate pooled estimates of sensitivity and specificity were generated using bivariate analyses with maximum likelihood estimates and 95% confidence intervals. We also conducted a narrative review on the impact of varying storage conditions or different cut-offs for detection from studies that undertook this in a subset of samples. The QUADAS-2 tool was used to assess risk of bias.

Results: In the quantitative synthesis for diagnostic accuracy of HBV-DNA using DBS, 521 citations were identified, and 12 studies met the inclusion criteria. Overall quality of studies was rated as low. The pooled estimate of sensitivity and specificity for HBV-DNA was 95% (95% CI: 83-99) and 99% (95% CI: 53-100), respectively. In the two studies that reported on cut-offs and limit of detection (LoD) - one reported a sensitivity of 98% for a cut-off of ≥2000 IU/ml and another reported a LoD of 914 IU/ml using a commercial assay. Varying storage conditions for individual samples did not result in a significant variation of results. In the synthesis for diagnostic accuracy of HCV-RNA using DBS, 15 studies met the inclusion criteria, and this included six additional studies to a previously published review. The pooled sensitivity and specificity was 98% (95% CI:95-99) and 98% (95% CI:95-99.0), respectively. Varying storage conditions resulted in a decrease in accuracy for quantification but not for reported positivity.

Conclusions: These findings show a high level of diagnostic performance for the use of DBS for HBV-DNA and HCV-RNA detection. However, this was based on a limited number and quality of studies. There is a need for development of standardized protocols by manufacturers on the use of DBS with their assays, as well as for larger studies on use of DBS conducted in different settings and with varying storage conditions.

Keywords: Diagnostic accuracy; Dried blood spots (DBS); HBV DNA; HCV RNA; Virological testing.

Conflict of interest statement

Ethics approval and consent to participate

Not applicable. Consent and ethical approval was performed within the original studies.

Consent for publication

Not applicable.

Competing interests

No competing interests were declared.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Prisma flow chart of studies for the systematic review of detection of hepatitis B DNA from DBS samples compared to venous blood sampling (plasma/serum)
Fig. 2
Fig. 2
Forest plot of sensitivities and specificities of the use of DBS samples for detection of hepatitis B-DNA compared to serum samples
Fig. 3
Fig. 3
Prisma flow chart of studies for the systematic review of detection of hepatitis C RNA from DBS samples compared to venous blood sampling (plasma/serum)
Fig. 4
Fig. 4
Forest plot of sensitivities and specificities of the use of DBS samples for detection of hepatitis C-RNA compared to serum samples

References

    1. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–S57. doi: 10.1016/j.jhep.2014.07.027.
    1. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388(10049):1081–1088. doi: 10.1016/S0140-6736(16)30579-7.
    1. World Health Organization. Global Hepatitis Report. Geneva: World Health Organization; 2017.
    1. Omata M, Kanda T, Wei L, M-L Y, Chuang W-L, Ibrahim A, et al. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int. 2016;10(5):681–701. doi: 10.1007/s12072-016-9736-3.
    1. American Association for the Study of Liver Disease. Recommendations for Testing, Managing, and Treating Hepatitis C. AASLD IDSA; 2015. .
    1. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98. doi: 10.1007/s12072-015-9675-4.
    1. World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015. .
    1. NICE. Diagnosis and management of chronic hepatitis B in children, young people and adults. 2013. .
    1. European Association For The Study Of The Liver EASL clinical practice guidelines: clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(1):370–398.
    1. Snijdewind IJM, van Kampen JJA, Fraaij PLA, van der Ende ME, Osterhaus ADME, Gruters RA. Current and future applications of dried blood spots in viral disease management. Antivir Res. 2012;93(3):309–321. doi: 10.1016/j.antiviral.2011.12.011.
    1. Komas NP, Vickos U, Hubschen JM, Bere A, Manirakiza A, Muller CP, et al. Cross-sectional study of hepatitis B virus infection in rural communities, Central African Republic. BMC Infect Dis. 2013;13(286):286. doi: 10.1186/1471-2334-13-286.
    1. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries. 2010;4(3):144–149.
    1. Costa ZB, Machado GC, Avelino MM, Gomes Filho C, Macedo Filho JV, Minuzzi AL, et al. Prevalence and risk factors for hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis. 2009;9:116. doi: 10.1186/1471-2334-9-116.
    1. Dube Q, Dow A, Chirambo C, Lebov J, Tenthani L, Moore M, et al. Implementing early infant diagnosis of HIV infection at the primary care level: experiences and challenges in Malawi. Bull World Health Organ. 2012;90(9):699–704. doi: 10.2471/BLT.11.100776.
    1. Smit PW, Sollis KA, Fiscus S, Ford N, Vitoria M, Essajee S, et al. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One. 2014;9(3):e86461. doi: 10.1371/journal.pone.0086461.
    1. Gupta BP, Jayasuryan N, Jameel S. Direct detection of hepatitis B virus from dried blood spots by polymerase chain reaction amplification. J Clin Microbiol. 1992;30(8):1913–1916.
    1. Smit PW, Elliott I, Peeling RW, Mabey D, Newton PN. Review article: an overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg. 2014;90(2):195–210. doi: 10.4269/ajtmh.13-0463.
    1. Greenman J, Roberts T, Cohn J, Messac L. Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review. J Viral Hepat. 2015;22(4):353–361. doi: 10.1111/jvh.12345.
    1. Lange B, Cohn J, Roberts T, Camp J, Chauffour J, Gummadi N, et al. Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses. BMC Infect Dis. 2017;17(1). Suppl doi:10.1186/s12879-017-2777-y.
    1. World Health Organization. Guidelines on Hepatitis B and C Testing. Geneva: World Health Organization; 2017. .
    1. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. doi: 10.7326/0003-4819-155-8-201110180-00009.
    1. Naaktgeboren CA, Ochodo EA, Van Enst WA, de Groot JAH, Hooft L, Leeflang MMG, et al. Assessing variability in results in systematic reviews of diagnostic studies. BMC Med Res Methodol. 2016;16(1):6. doi: 10.1186/s12874-016-0108-4.
    1. Alidjinou EK, Moukassa D, Sane F, Nyenyeli ST, Akoko EC, Mountou MV, et al. Detection of hepatitis B virus infection markers in dried plasma spots among patients in Congo-Brazzaville. Diagn Microbiol Infect Dis. 2014;78(3):229–231. doi: 10.1016/j.diagmicrobio.2013.09.019.
    1. Alhusseini NF, Abadeer MZ, El-Taher SM, Hepatitis B. Virus DNA can be amplified directly from dried blood spot on filter paper. Am J Biochem Biotechnol. 2012;8(2):143–149. doi: 10.3844/ajbbsp.2012.143.149.
    1. Jardi R, Rodriguez-Frias F, Buti M, Schaper M, Valdes A, Martinez M, et al. Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA. Hepatology. 2004;40(1):133–139. doi: 10.1002/hep.20275.
    1. Lira R, Maldonado-Rodriguez A, Rojas-Montes O, Ruiz-Tachiquin M, Torres-Ibarra R, Cano-Dominguez C, et al. Use of dried blood samples for monitoring hepatitis B virus infection. Virol J. 2009;6:153. doi: 10.1186/1743-422X-6-153.
    1. Mohamed S, Raimondo A, Penaranda G, Camus C, Ouzan D, Ravet S, et al. Dried blood spot sampling for hepatitis B virus serology and molecular testing. PLoS One. 2013;8(4):e61077. doi: 10.1371/journal.pone.0061077.
    1. Vinikoor MJ, Zurcher S, Musukuma K, Kachuwaire O, Rauch A, Chi BH, et al. Hepatitis B viral load in dried blood spots: a validation study in Zambia. J Clin Virol. 2015;72:20–24. doi: 10.1016/j.jcv.2015.08.019.
    1. Durgadevi S, Dhodapkar R, Parija SC. Serological and molecular diagnosis of hepatitis B virus. BMC Infect Dis Conference: 1st International Science Symposium on HIV and Infectious Diseases, HIV SCIENCE. 2012;20120120(20120122).
    1. Mossner BK, Staugaard B, Jensen J, Lillevang ST, Christensen PB, Holm DK. Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life. World J Gastroenterol. 2016;22(33):7604–7612. doi: 10.3748/wjg.v22.i33.7604.
    1. Stene-Johansen K, Yaqoob N, Overbo J, Aberra H, Desalegn H, Berhe N, et al. Dry blood spots a reliable method for measurement of hepatitis B viral load in resource-limited settings. PLoS One. 2016;11(11):e0166201. doi: 10.1371/journal.pone.0166201.
    1. Gruner N, Stambouli O, Ross RS. Dried blood spots--preparing and processing for use in immunoassays and in molecular techniques. J Visual Exp. 2015;97
    1. Ross RS, Stambouli O, Gruner N, Marcus U, Cai W, Zhang W, et al. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013;10:72. doi: 10.1186/1743-422X-10-72.
    1. Dokubo EK, Evans J, Winkelman V, Cyrus S, Tobler LH, Asher A, et al. Comparison of hepatitis C virus RNA and antibody detection in dried blood spots and plasma specimens. J Clin Virol. 2014;59(4):223–227. doi: 10.1016/j.jcv.2014.01.014.
    1. Marins EG, Bodinaidu K, Lin M, Deforest A. Evaluation of the COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HCV test v2.0 for HCV viral load monitoring using dried blood spot specimens. J Virol Methods. 2017;247:77–80. doi: 10.1016/j.jviromet.2017.05.016.
    1. Soulier A, Poiteau L, Rosa I, Hezode C, Roudot-Thoraval F, Pawlotsky JM, et al. Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring. J Infect Dis. 2016;213(7):1087–1095. doi: 10.1093/infdis/jiv423.
    1. Marques BL, do Espirito-Santo MP, Marques VA, Miguel JC, da Silva EF, Villela-Nogueira CA, et al. Evaluation of dried blood spot samples for hepatitis C virus detection and quantification. J Clin Virol. 2016;82:139–144. doi: 10.1016/j.jcv.2016.07.009.
    1. Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, et al. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat. 2011;18(4):262–270. doi: 10.1111/j.1365-2893.2010.01297.x.
    1. Bennett S, Gunson RN, McAllister GE, Hutchinson SJ, Goldberg DJ, Cameron SO, et al. Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol. 2012;54(2):106–109. doi: 10.1016/j.jcv.2012.02.004.
    1. Santos C, Reis A, Dos Santos CV, Damas C, Silva MH, Viana MV, et al. The use of real-time PCR to detect hepatitis C virus RNA in dried blood spots from Brazilian patients infected chronically. J Virol Methods. 2012;179(1):17–20. doi: 10.1016/j.jviromet.2011.06.012.
    1. De Crignis E, Re MC, Cimatti L, Zecchi L, Gibellini D. HIV-1 and HCV detection in dried blood spots by SYBR green multiplex real-time RT-PCR. J Virol Methods. 2010;165(1):51–56. doi: 10.1016/j.jviromet.2009.12.017.
    1. Tuaillon E, Mondain AM, Meroueh F, Ottomani L, Picot MC, Nagot N, et al. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology. 2010;51(3):752–758.
    1. Plamondon M, Labbe AC, Frost E, Deslandes S, Alves AC, Bastien N, et al. Hepatitis C virus infection in Guinea-Bissau: a sexually transmitted genotype 2 with parenteral amplification? PLoS One. 2007;2(4):e372. doi: 10.1371/journal.pone.0000372.
    1. Abe K, Konomi N, Hepatitis C. Virus RNA in dried serum spotted onto filter paper is stable at room temperature. J Clin Microbiol. 1998;36(10):3070–3072.
    1. Solmone M, Girardi E, Costa F, Ippolito G, Capobianchi M. Simple and reliable method for HCV-RNA detection/genotyping in dried blood spots. J Hepatol. 2002;36:131. doi: 10.1016/S0168-8278(02)80468-8.
    1. Cohn J, Roberts T, Amorosa V, Lemoine M, Hill A. Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatment. Curr Opin HIV AIDS. 2015;10(5):369–373. doi: 10.1097/COH.0000000000000180.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi